Evidence map›Paper›PMID 24145748›Full record

ArticleInternational journal of molecular sciences2013

DNA damage induced MutS homologue hMSH4 acetylation.

Yen-Lin Chu, Xiling Wu, Jing Xu, Jennifer L Watts, Chengtao Her

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yen-Lin ChuSchool of Molecular Biosciences, Mail Drop 64-7520, Washington State University, Pullman, WA 99164-7520, USA. cher@vetmed.wsu.edu.
Xiling Wu
Jing Xu
Jennifer L Watts
Chengtao Her
Washington State University · US

Funding

Roles of hMSH5 in DNA recombination and cellular response to anticancer treatmenR01GM084353 · NIGMS · WASHINGTON STATE UNIVERSITY · PI HER, CHENGTAO · 2010 to 2013
$1.1M
NIGMS NIH HHS GM084353NIGMS NIH HHS R01 GM084353
6 · The paper itself

Abstract

Acetylation of non-histone proteins is increasingly recognized as an important post-translational modification for controlling the actions of various cellular processes including DNA repair and damage response. Here, we report that the human MutS homologue hMSH4 undergoes acetylation following DNA damage induced by ionizing radiation (IR). To determine which acetyltransferases are responsible for hMSH4 acetylation in response to DNA damage, potential interactions of hMSH4 with hTip60, hGCN5, and hMof were analyzed. The results of these experiments indicate that only hMof interacts with hMSH4 in a DNA damage-dependent manner. Intriguingly, the interplay between hMSH4 and hMof manipulates the outcomes of nonhomologous end joining (NHEJ)-mediated DNA double strand break (DSB) repair and thereby controls cell survival in response to IR. This study also shows that hMSH4 interacts with HDAC3, by which HDAC3 negatively regulates the levels of hMSH4 acetylation. Interestingly, elevated levels of HDAC3 correlate with increased NHEJ-mediated DSB repair, suggesting that hMSH4 acetylation per se may not directly affect the role of hMSH4 in DSB repair.

Indexed as

AcetylationCell Cycle ProteinsCell LineCell Line, TumorCell SurvivalDNA Breaks, Double-StrandedDNA DamageDNA RepairHEK293 CellsHeLa CellsHistone AcetyltransferasesHistone Deacetylase 3Histone DeacetylasesHumansRadiation, IonizingCell Cycle ProteinsHistone AcetyltransferasesHistone Deacetylase 3Histone DeacetylasesKAT8 protein, humanMSH4 protein, human

Identifiers

PMID24145748
PMCPMC3821653
OpenAlexW2028838050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.